Stay updated on Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.
Latest updates to the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check24 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.2%
- Check52 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check74 days agoChange DetectedSeveral key resources related to soft tissue sarcoma, including links to MedlinePlus and NIH, have been removed, which may impact access to important information on treatments and studies.SummaryDifference3%
Stay in the know with updates to Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.